Table 1. Patient characteristics No. .... | American Society of Hematology

Table 1.

Patient characteristics

No.	Sex/age, y	BM involvement by biopsy or aspirate, %	Disease status	R-ISS	Prior radiotherapy	Previous therapy	Dose of unlabeled Dara, mg
1	Male/59	25	Newly diagnosed	Stage II	Yes		0
2	Male/70	6	Relapse by PET	Unknown	No	RVD, autologous stem cell transplantation; lenalidomide maintenance	0
3	Male/69	1	Relapse in pleural lesion by PET	Stage III	Yes	RVD; pomalidomide, daratumumab, dexamethasone; autologous stem cell transplantation	0
4	Male/62	6.4	Relapse by minimal positive PET	Stage I	No	RVD	10
5	Female/52	2	Relapse by PET: diffuse widespread lytic lesions	Stage II	No	RVD	10
6	Female/55	5	Biochemical relapse	Stage I	No	RVD; autologous stem cell transplantation	10
7	Female/55	60	Newly diagnosed	Stage I	No		45
8	Female/64	60	Newly diagnosed	Stage II	No		45
9	Male/67	0	Recurrent plasmacytoma	Unknown	Yes		45
10	Female/61	40	Newly diagnosed	Stage I	No		95
11	Male/72	0	Suspicion of relapse as detected by MRI	Stage III	No	RVD; autologous stem cell transplantation; carfilzomib, lenalidomide, dexamethasone; daratumumab, lenalidomide	95
12	Female/78	40	Newly diagnosed		No		95

No.	Sex/age, y	BM involvement by biopsy or aspirate, %	Disease status	R-ISS	Prior radiotherapy	Previous therapy	Dose of unlabeled Dara, mg
1	Male/59	25	Newly diagnosed	Stage II	Yes		0
2	Male/70	6	Relapse by PET	Unknown	No	RVD, autologous stem cell transplantation; lenalidomide maintenance	0
3	Male/69	1	Relapse in pleural lesion by PET	Stage III	Yes	RVD; pomalidomide, daratumumab, dexamethasone; autologous stem cell transplantation	0
4	Male/62	6.4	Relapse by minimal positive PET	Stage I	No	RVD	10
5	Female/52	2	Relapse by PET: diffuse widespread lytic lesions	Stage II	No	RVD	10
6	Female/55	5	Biochemical relapse	Stage I	No	RVD; autologous stem cell transplantation	10
7	Female/55	60	Newly diagnosed	Stage I	No		45
8	Female/64	60	Newly diagnosed	Stage II	No		45
9	Male/67	0	Recurrent plasmacytoma	Unknown	Yes		45
10	Female/61	40	Newly diagnosed	Stage I	No		95
11	Male/72	0	Suspicion of relapse as detected by MRI	Stage III	No	RVD; autologous stem cell transplantation; carfilzomib, lenalidomide, dexamethasone; daratumumab, lenalidomide	95
12	Female/78	40	Newly diagnosed		No		95

MRI, magnetic resonance imaging; RVD, lenalidomide/bortezomib/dexamethasone.